94 Results for "

VX

" in MedChemExpress (MCE) Product Catalog:
Products (94)

94 Results for "VX" in MCE Product Catalog:

177
177 Publications Verification
Cat. No.: HY-13205
CAS No.: 273404-37-8
Purity:  99.99%
Synonyms: VX-765
Target:  

Caspase

Research Areas:  

Inflammation/Immunology

Belnacasan (VX-765) is an orally bioactive proagent of VRT-043198, which is a potent and selective inhibitor of IL-converting enzyme (ICE)/caspase-1 with Kis of 0.8 nM and less than 0.6 nM for caspase-1 and caspase-4, respectively. Belnacasan (VX-765) inhibits the release of LPS-induced IL-1β and IL-18 by human PBMCs with an IC50 of ~0.7 μM .
loading...
    loading...
51
51 Cited Publications
Cat. No.: HY-111772
CAS No.: 2216712-66-0
Purity:  99.74%
Synonyms: VX-445
Target:  

CFTR Autophagy

Research Areas:  

Inflammation/Immunology

Elexacaftor (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR). Elexacaftor (VX-445, Compound 1) facilitates the processing and trafficking of CFTR to increase the amount of CFTR at the cell surface .
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-10235
CAS No.: 402957-28-2
Purity:  99.54%
Synonyms: VX-950
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, the steady-state inhibitory constant (Ki) of Telaprevir is 7 nM against a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide . Telaprevir inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-13017
CAS No.: 873054-44-5
Purity:  99.97%
Synonyms: VX-770
Target:  

CFTR Autophagy

Research Areas:  

Endocrinology

Ivacaftor (VX-770) is a potent and orally bioavailable CFTR potentiator, targeting G551D-CFTR and F508del-CFTR with EC50s of 100 nM and 25 nM, respectively.
loading...
    loading...
28
28 Cited Publications
Cat. No.: HY-15448
CAS No.: 1152311-62-0
Purity:  99.85%
Synonyms: VX-661
Target:  

CFTR

Research Areas:  

Cancer

Tezacaftor (VX-661) is a F508del CFTR corrector. It helps CFTR protein reach the cell surface. However, Ivacaftor (VX-770, HY-13017), a CFTR potentiator, helps to prolong the opening time of cell surface CFTR protein channels. Tezacaftor combining with Ivacaftor, shows potent efficacy against cystic fibrosis and diseases with homozygous for the CFTR Phe508del mutation. Moreover, Elexacaftor (VX-445, HY-111772) is also a CFTR corrector. Elexacaftor-Tezacaftor-Ivacaftor aims at with cystic fibrosis (CF) with at least one Phe508del mutation, often avoids the indication for lung transplantation .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-13902
CAS No.: 1232416-25-9
Purity:  99.70%
Synonyms: VE-822; VX-970; M6620
Research Areas:  

Infection Metabolic Disease Cancer

Berzosertib (VE-822) is an orally active, CNS-penetrant, and selective ATR kinase inhibitor. Berzosertib blocks ATR kinase activity, abrogates G2/M cell cycle checkpoint, impairs DNA damage repair. Berzosertib induces apoptosis, inhibnits conlony migration, inhibits cell proliferation, and activates cGAS-STING axes in cancer cells. Berzosertib can be used for the research of cancers, such as head and neck squamous cell carcinoma, and colorectal cancer .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-13902A
CAS No.: 1428935-04-9
Synonyms: VE-822 hydrochloride; VX-970 hydrochloride; M6620 hydrochloride
Research Areas:  

Neurological Disease Cancer

Berzosertib (VE-822) hydrochloride is an orally active, CNS-penetrant, and selective ATR kinase inhibitor. Berzosertib hydrochloride blocks ATR kinase activity, abrogates G2/M cell cycle checkpoint, impairs DNA damage repair. Berzosertib hydrochloride induces apoptosis, inhibnits conlony migration, inhibits cell proliferation, and activates cGAS-STING axes in cancer cells. Berzosertib hydrochloride can be used for the research of cancers, such as head and neck squamous cell carcinoma, and colorectal cancer .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-13262
CAS No.: 936727-05-8
Purity:  99.85%
Synonyms: VX-809; VRT 826809
Target:  

CFTR Autophagy

Research Areas:  

Inflammation/Immunology

Lumacaftor (VX-809; VRT 826809) is a CFTR modulator that corrects the folding and trafficking of CFTR protein.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-10161
CAS No.: 639089-54-6
Purity:  99.92%
Synonyms: VX 680; MK-0457
Target:  

Aurora Kinase Autophagy

Research Areas:  

Cancer

Tozasertib (VX 680; MK-0457) is an inhibitor of Aurora A/B/C kinases with Kis of 0.6, 18, 4.6 nM, respectively.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-10328
CAS No.: 209410-46-8
Purity:  99.32%
Synonyms: VX-745
Target:  

p38 MAPK Autophagy

Research Areas:  

Inflammation/Immunology

Neflamapimod (VX-745) is a potent, blood-brain barrier penetrant, highly selective inhibitor of p38α inhibitor with an IC50 for p38α of 10 nM and for p38β of 220 nM. Neflamapimod (VX-745) possesses anti-inflammatory activity.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-14178
CAS No.: 896720-20-0
Purity:  98.94%
Target:  

ERK

Research Areas:  

Cancer

VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-12353A
CAS No.: 1629869-44-8
Purity:  99.40%
Synonyms: VX-787
Target:  

Influenza Virus

Research Areas:  

Infection

Pimodivir (VX-787) is an orally bioavailable inhibitor of influenza A virus polymerases through interaction with the viral PB2 subunit.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-13252
CAS No.: 1010085-13-8
Purity:  99.89%
Synonyms: VX-689
Target:  

Aurora Kinase Autophagy

Research Areas:  

Cancer

MK-5108 is a highly potent and specific inhibitor of Aurora A kinase with an IC50 value of 0.064 nM.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-17430
CAS No.: 161814-49-9
Synonyms: VX-478
Target:  

HIV HIV Protease SARS-CoV

Research Areas:  

Infection Cancer

Amprenavir (VX-478) is a HIV protease inhibitor (Ki=0.6 nM) used to treat HIV infection. Amprenavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.09 μM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-148800
CAS No.: 2649467-58-1
Purity:  99.96%
Synonyms: VX-548
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Suzetrigine (VX-548) is an orally active and highly selective NaV1.8 inhibitor that acts as an analgesic. Suzetrigine is also a blocker of sodium channel protein type 10 subunit alpha. Suzetrigine is promising for research of acute pain after abdominoplasty and bunionectomy .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-136270
CAS No.: 1613191-99-3
Purity:  99.77%
Synonyms: VX-803; M4344; ATR inhibitor 2
Target:  

ATM/ATR

Research Areas:  

Cancer

Gartisertib (VX-803) is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of <150 pM. Gartisertib potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation with an IC50 of 8 nM. Antitumor activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13560
CAS No.: 297730-17-7
Purity:  99.89%
Synonyms: VX-944
AVN-944 (VX-944) is an orally active, potent, selective, noncompetitive and specific inhibitor of IMPDH (inosine monophosphate dehydrogenase). AVN-944 is an essential rate-limiting enzyme in de novo guanine nucleotide synthesis. AVN-944 is also an inhibitor of arenavirus RNA synthesis, and blocks arenavirus infection. AVN-944 has broad anti-cancer activities, and can be used for multiple myeloma (MM) and acute myeloid leukemia (AML) research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-145603
CAS No.: 2374124-49-7
Purity:  98.19%
Synonyms: VX-121
Target:  

CFTR Chloride Channel

Research Areas:  

Neurological Disease

Vanzacaftor (VX-121) is an orally active noval corrector of Cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor improves processing and trafficking of CFTR protein as well as increases chloride transport in triple combined with Tezacaftor (HY-15448) and Deutivacaftor. Vanzacaftor-Tezacaftor-Deutivacaftor is safe and well tolerated, improving lung function, respiratory symptoms, and CFTR function with cystic fibrosis, which is promising for research in the field of cystic fibrosis diseases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10401
CAS No.: 745833-23-2
Purity:  99.54%
Target:  

p38 MAPK Autophagy

Research Areas:  

Inflammation/Immunology

VX-702 is a highly selective inhibitor of p38α MAPK, 14-fold higher potency against the p38α versus p38β .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19939S
CAS No.: 1476074-39-1
Synonyms: M9831
VX-984 is an orally active, potent, selective and BBB-penetrated DNA-PK inhibitor. VX-984 efficiently inhibits NHEJ (non-homologous end joining) and increases DSBs (DNA double-strand breaks). VX-984 can be used for glioblastomas (GBM) and non-small cell lung cancer (NSCLC) research. VX-984 is a de novo deuterium .
loading...
    loading...